Delving into the Latest Updates on Wuhan Zhong Yuan Rui de Biologicals Products Co., Ltd. with Synapse

Overview

Chengdu Rongsheng Pharmaceutical Co., Ltd. entered into an agreement to acquire RUIDE OPERATIONS of CSL Limited from CSL Limited (ASX:CSL) for approximately $190 million on August 30, 2024. The transaction is subject to approval by relevant government authorities. The transaction is expected to close by the end of calendar year 2024.

Acquisition

100 Deals associated with Wuhan Zhong Yuan Rui de Biologicals Products Co., Ltd.

Login to view more data

100 Translational Medicine associated with Wuhan Zhong Yuan Rui de Biologicals Products Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 May 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data